genuine question about UK that I am slightly embarrassed to ask
Question in the title, detail here: genuine question about UK that I am slightly embarrassed to ask. Read the MHRA notice rather than the news coverage and the actual scope was much narrower than the panic threads suggested. The two routes, described separately, because mixing them is where most of the confusion here…
Supply notices from the regulator describe expected availability at a national level. They do not predict what any individual pharmacy has on the shelf next week.
tier 3 waiting lists are measured in years, not months
an online consultation that asks you nothing is not a consultation
Which nation, and which ICB if you are in England?
an online consultation that asks you nothing is not a consultation
Adding the practical bit — ask what happens at discharge before you start, not after.
How long have you been on the list, and from what date?
Concentrations can differ between products and between pharmacies. Switching mid-titration means redoing the arithmetic rather than carrying the old unit count across.
Which pharmacy, and what did they quote for the month rather than the first month?
Careful, that pricing figure is a headline offer with conditions attached rather than the actual monthly cost.
the price difference between pharmacies this month is genuinely large
BMI thresholds vary by ICB and by year